OrganaBio Adds Perinatal and Adult Tissues for Clinical Manufacturing to its Portfolio of Products for Allogeneic Cell Therapy Development
MIAMI–(BUSINESS WIRE)– #CellTherapy–OrganaBio’s cGMP umbilical cord blood and leukopak products support translational researchers’ need for critical, clinical-grade cellular materials.
Powered by WPeMatico